• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Cryopreserved amniotic membrane – Market size and forecast 2020-2025
o Dehydrated amniotic membrane – Market size and forecast 2020-2025
o Market opportunity by Type
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Celularity Inc.
o Human Regenerative Technologies LLC
o Integra LifeSciences Holdings Corp.
o Katena Products Inc.
o MiMedx Group Inc.
o NuVision Biotherapies Ltd.
o Orthofix Medical Inc.
o Stryker Corp.
o Surgenex LLC
o TissueTech Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Type – Market share 2020-2025 (%)
• 22: Comparison by Type
• 23: Cryopreserved amniotic membrane – Market size and forecast 2020-2025 ($ million)
• 24: Cryopreserved amniotic membrane – Year-over-year growth 2020-2025 (%)
• 25: Dehydrated amniotic membrane – Market size and forecast 2020-2025 ($ million)
• 26: Dehydrated amniotic membrane – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Type
• 28: Customer landscape
• 29: Market share by geography 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity by geography ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: Celularity Inc. – Overview
• 48: Celularity Inc. – Product and service
• 49: Celularity Inc. – Key offerings
• 50: Celularity Inc. – Key customers
• 51: Celularity Inc. – Segment focus
• 52: Human Regenerative Technologies LLC – Overview
• 53: Human Regenerative Technologies LLC – Product and service
• 54: Human Regenerative Technologies LLC – Key offerings
• 55: Human Regenerative Technologies LLC – Key customers
• 56: Human Regenerative Technologies LLC – Segment focus
• 57: Integra LifeSciences Holdings Corp. – Overview
• 58: Integra LifeSciences Holdings Corp. – Business segments
• 59: Integra LifeSciences Holdings Corp. – Key offerings
• 60: Integra LifeSciences Holdings Corp. – Key customers
• 61: Integra LifeSciences Holdings Corp. – Segment focus
• 62: Katena Products Inc. – Overview
• 63: Katena Products Inc. – Product and service
• 64: Katena Products Inc. – Key offerings
• 65: Katena Products Inc. – Key customers
• 66: Katena Products Inc. – Segment focus
• 67: MiMedx Group Inc. – Overview
• 68: MiMedx Group Inc. – Business segments
• 69: MiMedx Group Inc. – Key offerings
• 70: MiMedx Group Inc. – Key customers
• 71: MiMedx Group Inc. – Segment focus
• 72: NuVision Biotherapies Ltd. – Overview
• 73: NuVision Biotherapies Ltd. – Product and service
• 74: NuVision Biotherapies Ltd. – Key offerings
• 75: NuVision Biotherapies Ltd. – Key customers
• 76: NuVision Biotherapies Ltd. – Segment focus
• 77: Orthofix Medical Inc. – Overview
• 78: Orthofix Medical Inc. – Business segments
• 79: Orthofix Medical Inc. – Key offerings
• 80: Orthofix Medical Inc. – Key customers
• 81: Orthofix Medical Inc. – Segment focus
• 82: Stryker Corp. – Overview
• 83: Stryker Corp. – Business segments
• 84: Stryker Corp. – Key offerings
• 85: Stryker Corp. – Key customers
• 86: Stryker Corp. – Segment focus
• 87: Surgenex LLC – Overview
• 88: Surgenex LLC – Product and service
• 89: Surgenex LLC – Key offerings
• 90: Surgenex LLC – Key customers
• 91: Surgenex LLC – Segment focus
• 92: TissueTech Inc. – Overview
• 93: TissueTech Inc. – Product and service
• 94: TissueTech Inc. – Key offerings
• 95: TissueTech Inc. – Key customers
• 96: TissueTech Inc. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations
❖ 掲載企業 ❖
Celularity Inc., Stryker Corp., Surgenex LLC, Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc.TissueTech Inc., Integra LifeSciences Holdings Corp., Human Regenerative Technologies LLC